Evidence map›Paper›PMID 40486788›Full record

ReviewJSES international2025

Robot-assisted shoulder arthroplasty.

Joaquin Sanchez-Sotelo

Abstract readReview
In one paragraph

Review in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joaquin Sanchez-SoteloDivision of Shoulder and Elbow Surgery, Department of Orthepedic Surgery, Mayo Clinic, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic assistance has demonstrated to provide value in the field of hip and knee arthroplasty. As a result, it is becoming increasingly popular. On the contrary, robot-assisted shoulder arthroplasty is in its infancy. The various commercially available robots for arthroplasty applications are quite different regarding the features they provide. For shoulder arthroplasty, the Rosa system is already available to selected users, and the Mako system will be available soon. Rosa is considered a collaborative robot that positions cutting guides and reamers as a combined effort between the robot and the surgeon; once the desired position of the guide or reamer is achieved, the robot enters static mode, and the surgeon performs the humerus osteotomy or reams the glenoid in collaboration with the robot; currently, augment preparation is not provided. Mako provides an effector end that prepares bone and uses haptic boundaries to avoid error; details on the Mako shoulder application have not been released. The main theoretical benefits of robot-assisted shoulder arthroplasty include accuracy and precision, data acquisition, and with certain robots, the promise to avoid soft-tissue injury with haptic boundaries, prepare a bone through minimally invasive or cuff-preserving exposures, and the potential for motion assessment and soft-tissue balance. The disadvantages include cost, a certain learning curve, complications related to array insertion, potential for cognitive bias, need for a larger operating room space, and the potential for malfunction. Although adoption is likely to happen in many centers, cost and space constrains may favor alternative technologies, such as mixed reality navigation, especially in ambulatory surgery centers.

Indexed as

Anatomic shoulder arthroplastyDigital enabling technologiesMakoReverse shoulder arthroplastyRobotic surgeryRosaShoulder arthroplasty

Identifiers

PMID40486788
PMCPMC12145009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.